MetaVia Inc. — Director's Dealing 2022

Jul 29, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2022-07-26

Reporting Person: E&Investment, Inc. (10% Owner)
Reporting Person: E&Healthcare Investment Fund II (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-26	Common Stock	J	1445267	—	Disposed	2890533	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	140147	Direct
Common Stock	1121190	Indirect
Common Stock	1864799	Indirect

Footnotes

F1: E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.

F2: These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.

F3: E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

F4: E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.

F5: These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.

F6: These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.